AstraZeneca Aktie
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Diese Analysten bewerten die AstraZeneca-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Deutsche Bank AG | 120,00 GBP | - | 09.11.2026 | |
| Jefferies & Company Inc. | 175,00 GBP | - | 05.11.2026 | |
| DZ BANK | - | - | 03.11.2026 | |
| Goldman Sachs Group Inc. | 175,80 GBP | - | 03.11.2026 | |
| Bernstein Research | 205,00 GBP | - | 03.11.2026 | |
| UBS AG | 160,00 GBP | - | 02.11.2026 | |
| Barclays Capital | 170,00 GBP | - | 02.11.2026 | |
| RBC Capital Markets | 152,50 GBP | - | 02.11.2026 | |
| JP Morgan Chase & Co. | 160,00 GBP | - | 27.10.2026 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 150,00 GBP | - | 16.10.2026 |
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 9 | 1 | 0 | 163,14 GBP | - |
| Bayer | 7 | 2 | 0 | 58,31 EUR | +3,75% |
| BioNTech (ADRs) | 5 | 2 | 0 | 121,84 USD | +44,24% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 0 | 0 | - | - |
| EVOTEC SE | 1 | 2 | 0 | 4,08 EUR | +46,34% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 3 | 5 | 0 | 149,00 EUR | -0,40% |
| Moderna Inc | 0 | 1 | 0 | 45,00 USD | -78,33% |
| Novartis AG | 1 | 7 | 2 | 123,90 CHF | -7,04% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 1 | 6 | 1 | 28,43 USD | -0,14% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Roche Holding AG Inhaber-Partizipationsschein | 4 | 4 | 1 | 383,44 CHF | -5,60% |
| Sanofi S.A. | 5 | 5 | 0 | 94,11 EUR | +8,53% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |